Swiss cost-effectiveness analysis of universal screening for Lynch syndrome of patients with colorectal cancer followed by cascade genetic testing of relatives

BACKGROUND: We estimated the cost-effectiveness of universal DNA screening for Lynch syndrome (LS) among newly diagnosed patients with colorectal cancer (CRC) followed by cascade screening of relatives from the Swiss healthcare system perspective. METHODS: We integrated decision trees with Markov mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Salikhanov, Islam, Heinimann, Karl, Chappuis, Pierre, Buerki, Nicole, Graffeo, Rossella, Heinzelmann, Viola, Rabaglio, Manuela, Taborelli, Monica, Wieser, Simon, Katapodi, Maria C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Screening
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411888/
https://www.ncbi.nlm.nih.gov/pubmed/34782441
http://dx.doi.org/10.1136/jmedgenet-2021-108062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411888/
https://www.ncbi.nlm.nih.gov/pubmed/34782441
http://dx.doi.org/10.1136/jmedgenet-2021-108062

Ejemplares similares